FIELD: medicine.
SUBSTANCE: obtained is polypeptide of the following formula: U-X19-X20-X21-X22-X23-X24-X25-X26-X27-X28-X29-X30-X31-X32-Z, with U=X18, X17-X18, X16-X17-X18, X15-X16-X17-X18, X14-X15-X16-X17-X18, X13-X14-X15-X16-X17-X18, X12-X13-X14-X15-X16-X17-X18, X11-X12-X13-X14-X15-X16-X17-X18, X10-X11-X12-X13-X14-X15-X16-X17-X18, X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X5-X6-X7-X8- X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X4-X5-X6-X7-X8- X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X3-X4-X5-X6-X7-X8- X9-X10-X11-X12-X13-X14-X15-X16-X17-X18, X2-X3-X4-X5-X6-X7-X8- X9-X10-X11-X12-X13-X14-X15-X16-X17-X18 or X1-X2-X3-X4-X5-X6-X7-X8- X9-X10-X11-X12-X13-X14-X15-X16-X17-X18; Z=X33, X33-X34, X33-X34-X35, X33-X34-X35-X36, X33-X34-X35-X36-X37, X33-X34-X35-X36-X37-X38, X33-X34-X35-X36-X37-X38-X39, X33-X34-X35-X36-X37-X38-X39-X40 or X33-X34-X35-X36-X37-X38-X39-X40-X41; X1=Ser; X2=Glu; X3=Thr; X4=Arg; X5=Pro; X6=Val; X7=Leu; X8=Asn; X9=Arg; X10=Leu; X11=Phe; X12=Asp; X13=Lys; X14=Ile; X15=Arg; X16=Gln; X17=Val; X18=Ile; X19=Arg; X20=Lys; X21=Phe; X22=Glu; X23=Lys; X24=Gly; X25=Ile; X26=Lys; X27=Glu; X28=Lys; X29=Ser; X30=Lys; X31=Arg; X32=Phe; X33=Phe; X34=Asp; X35=Gly; X36=Leu; X37=Leu; X38=Ala; X39=Phe; X40=Arg; X41=Lys.
EFFECT: invention makes it possible to obtain polypeptide, efficient in treatment and prevention of human bacterial infections.
8 cl, 2 dwg, 17 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
GENE-THERAPEUTIC METHODS FOR ADMINISTRATION OF APOLIPOPROTEIN A-1 AGONISTS AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2222545C2 |
AGONISTS OF APOLIPOPROTEIN A-I AND THEIR USING FOR TREATMENT OF DYSLIPIDEMIA-MEDIATED DISEASES | 1998 |
|
RU2215747C2 |
METHOD OF PREDICTING FORMATION OF POST-OPERATION ABDOMINAL HERNIAS | 2008 |
|
RU2370216C1 |
AGONISTS OF APOLIPOPROTEIN A-1 AND THEIR APPLICATION FOR TREATMENT OF DYSLIPIDEMIA-ASSOCIATED DISEASES | 1998 |
|
RU2219941C2 |
A-I APOLIPOPROTEIN MIMETICS | 2010 |
|
RU2532222C2 |
ANTIGENIC PEPTIDES | 2003 |
|
RU2312941C2 |
ERGONOMIC QUALIMETRY METHOD OF COLLECTIVE NOISE PROTECTION DEVICE | 2016 |
|
RU2621428C1 |
AGONISTS OF APOLIPOPROTEIN A-1 AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2214831C2 |
METHOD OF AUTOMATIC CONTROL OF MELTING PROCESS OF COPPER-NICK SULPHIDE RAW MATERIAL IN VANYUKOV'S FURNACE DURING SULPHIDE CHARGE PROCESSING TO REGULUS | 2013 |
|
RU2571968C2 |
HIGH-AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR | 2014 |
|
RU2663106C2 |
Authors
Dates
2011-11-27—Published
2010-07-21—Filed